FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011014387> ?p ?o ?g. }

• W2011014387 endingPage "6500" @default.
• W2011014387 startingPage "6496" @default.
• W2011014387 abstract "Ceftaroline (CPT), the active metabolite of the prodrug ceftaroline-fosamil (CPT-F), demonstrates in vitro bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA) and is effective in rabbit models of difficult-to-treat MRSA endocarditis and acute osteomyelitis. However, its in vivo efficacy in a prosthetic joint infection (PJI) model is unknown. Using a MRSA-infected knee PJI model in rabbits, the efficacies of CPT-F or vancomycin (VAN) alone and combined with rifampin (RIF) were compared. After each partial knee replacement with a silicone implant that fit into the tibial intramedullary canal was performed, 5 × 10(7) MRSA CFU (MICs of 0.38, 0.006, and 1 mg/liter for CPT, RIF, and VAN, respectively) was injected into the knee. Infected animals were randomly assigned to receive no treatment (controls) or CPT-F (60 mg/kg of body weight intramuscularly [i.m.]), VAN (60 mg/kg i.m.), CPT-F plus RIF (10 mg/kg i.m.), or VAN plus RIF starting 7 days postinoculation and lasting for 7 days. Surviving bacteria in crushed tibias were counted 3 days after ending treatment. Although the in vivo mean log10 CFU/g of CPT-treated (3.0 ± 0.9, n = 12) and VAN-treated (3.5 ± 1.1, n = 12) crushed bones was significantly lower than those of controls (5.6 ± 1.1, n = 14) (P < 0.001), neither treatment fully sterilized the bones (3/12 were sterile with each treatment). The mean log10 CFU/g values for the antibiotics in combination with RIF were 1.9 ± 0.5 (12/14 were sterile) for CPT-F and 1.9 ± 0.5 (12/14 were sterile) for VAN. In this MRSA PJI model, the efficacies of CPT-F and VAN did not differ; thus, CPT appears to be a promising antimicrobial agent for the treatment of MRSA PJIs." @default.
• W2011014387 created "2016-06-24" @default.
• W2011014387 creator A5016723451 @default.
• W2011014387 creator A5021378333 @default.
• W2011014387 creator A5032750104 @default.
• W2011014387 creator A5051370089 @default.
• W2011014387 creator A5069009054 @default.
• W2011014387 creator A5084622139 @default.
• W2011014387 date "2014-11-01" @default.
• W2011014387 modified "2023-10-16" @default.
• W2011014387 title "Ceftaroline-Fosamil Efficacy against Methicillin-Resistant Staphylococcus aureus in a Rabbit Prosthetic Joint Infection Model" @default.
• W2011014387 cites W1972342488 @default.
• W2011014387 cites W1983255179 @default.
• W2011014387 cites W2000958961 @default.
• W2011014387 cites W2008189375 @default.
• W2011014387 cites W2026372260 @default.
• W2011014387 cites W2038708693 @default.
• W2011014387 cites W2071260810 @default.
• W2011014387 cites W2075359954 @default.
• W2011014387 cites W2109417549 @default.
• W2011014387 cites W2122767456 @default.
• W2011014387 cites W2136296616 @default.
• W2011014387 cites W2137811656 @default.
• W2011014387 cites W2138194474 @default.
• W2011014387 cites W2142580580 @default.
• W2011014387 cites W2148821424 @default.
• W2011014387 cites W2161612915 @default.
• W2011014387 cites W4214754383 @default.
• W2011014387 doi "https://doi.org/10.1128/aac.03600-14" @default.
• W2011014387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4249363" @default.
• W2011014387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25136014" @default.
• W2011014387 hasPublicationYear "2014" @default.
• W2011014387 type Work @default.
• W2011014387 sameAs 2011014387 @default.
• W2011014387 citedByCount "16" @default.
• W2011014387 countsByYear W20110143872015 @default.
• W2011014387 countsByYear W20110143872016 @default.
• W2011014387 countsByYear W20110143872017 @default.
• W2011014387 countsByYear W20110143872018 @default.
• W2011014387 countsByYear W20110143872019 @default.
• W2011014387 countsByYear W20110143872020 @default.
• W2011014387 countsByYear W20110143872021 @default.
• W2011014387 countsByYear W20110143872022 @default.
• W2011014387 crossrefType "journal-article" @default.
• W2011014387 hasAuthorship W2011014387A5016723451 @default.
• W2011014387 hasAuthorship W2011014387A5021378333 @default.
• W2011014387 hasAuthorship W2011014387A5032750104 @default.
• W2011014387 hasAuthorship W2011014387A5051370089 @default.
• W2011014387 hasAuthorship W2011014387A5069009054 @default.
• W2011014387 hasAuthorship W2011014387A5084622139 @default.
• W2011014387 hasBestOaLocation W20110143871 @default.
• W2011014387 hasConcept C141071460 @default.
• W2011014387 hasConcept C150903083 @default.
• W2011014387 hasConcept C207001950 @default.
• W2011014387 hasConcept C2775965595 @default.
• W2011014387 hasConcept C2777052132 @default.
• W2011014387 hasConcept C2777334864 @default.
• W2011014387 hasConcept C2778980435 @default.
• W2011014387 hasConcept C2779489039 @default.
• W2011014387 hasConcept C2780551157 @default.
• W2011014387 hasConcept C3019249092 @default.
• W2011014387 hasConcept C501593827 @default.
• W2011014387 hasConcept C523546767 @default.
• W2011014387 hasConcept C54355233 @default.
• W2011014387 hasConcept C71924100 @default.
• W2011014387 hasConcept C86803240 @default.
• W2011014387 hasConcept C89423630 @default.
• W2011014387 hasConceptScore W2011014387C141071460 @default.
• W2011014387 hasConceptScore W2011014387C150903083 @default.
• W2011014387 hasConceptScore W2011014387C207001950 @default.
• W2011014387 hasConceptScore W2011014387C2775965595 @default.
• W2011014387 hasConceptScore W2011014387C2777052132 @default.
• W2011014387 hasConceptScore W2011014387C2777334864 @default.
• W2011014387 hasConceptScore W2011014387C2778980435 @default.
• W2011014387 hasConceptScore W2011014387C2779489039 @default.
• W2011014387 hasConceptScore W2011014387C2780551157 @default.
• W2011014387 hasConceptScore W2011014387C3019249092 @default.
• W2011014387 hasConceptScore W2011014387C501593827 @default.
• W2011014387 hasConceptScore W2011014387C523546767 @default.
• W2011014387 hasConceptScore W2011014387C54355233 @default.
• W2011014387 hasConceptScore W2011014387C71924100 @default.
• W2011014387 hasConceptScore W2011014387C86803240 @default.
• W2011014387 hasConceptScore W2011014387C89423630 @default.
• W2011014387 hasIssue "11" @default.
• W2011014387 hasLocation W20110143871 @default.
• W2011014387 hasLocation W20110143872 @default.
• W2011014387 hasLocation W20110143873 @default.
• W2011014387 hasLocation W20110143874 @default.
• W2011014387 hasOpenAccess W2011014387 @default.
• W2011014387 hasPrimaryLocation W20110143871 @default.
• W2011014387 hasRelatedWork W2068279471 @default.
• W2011014387 hasRelatedWork W2103584054 @default.
• W2011014387 hasRelatedWork W2114826458 @default.
• W2011014387 hasRelatedWork W2131915708 @default.
• W2011014387 hasRelatedWork W2132965571 @default.
• W2011014387 hasRelatedWork W2137540804 @default.
• W2011014387 hasRelatedWork W2150224997 @default.
• W2011014387 hasRelatedWork W2170374595 @default.

• next